BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20371132)

  • 1. Antiproliferative effect of Aurora kinase targeting in mesothelioma.
    Crispi S; Fagliarone C; Biroccio A; D'Angelo C; Galati R; Sacchi A; Vincenzi B; Baldi A; Verdina A
    Lung Cancer; 2010 Dec; 70(3):271-9. PubMed ID: 20371132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.
    López-Ríos F; Chuai S; Flores R; Shimizu S; Ohno T; Wakahara K; Illei PB; Hussain S; Krug L; Zakowski MF; Rusch V; Olshen AB; Ladanyi M
    Cancer Res; 2006 Mar; 66(6):2970-9. PubMed ID: 16540645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of survivin and aurora B kinase sensitizes mesothelioma cells by enhancing mitotic arrests.
    Kim KW; Mutter RW; Willey CD; Subhawong TK; Shinohara ET; Albert JM; Ling G; Cao C; Gi YJ; Lu B
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1519-25. PubMed ID: 17394948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZM447439, the Aurora kinase B inhibitor, suppresses the growth of cervical cancer SiHa cells and enhances the chemosensitivity to cisplatin.
    Zhang L; Zhang S
    J Obstet Gynaecol Res; 2011 Jun; 37(6):591-600. PubMed ID: 21159048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trivalent dimethylarsenic compound induces histone H3 phosphorylation and abnormal localization of Aurora B kinase in HepG2 cells.
    Suzuki T; Miyazaki K; Kita K; Ochi T
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):275-82. PubMed ID: 19716834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores.
    Ditchfield C; Johnson VL; Tighe A; Ellston R; Haworth C; Johnson T; Mortlock A; Keen N; Taylor SS
    J Cell Biol; 2003 Apr; 161(2):267-80. PubMed ID: 12719470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validating Aurora B as an anti-cancer drug target.
    Girdler F; Gascoigne KE; Eyers PA; Hartmuth S; Crafter C; Foote KM; Keen NJ; Taylor SS
    J Cell Sci; 2006 Sep; 119(Pt 17):3664-75. PubMed ID: 16912073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma.
    Hartman ML; Esposito JM; Yeap BY; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1233-40. PubMed ID: 19853261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma.
    Aihara A; Tanaka S; Yasen M; Matsumura S; Mitsunori Y; Murakata A; Noguchi N; Kudo A; Nakamura N; Ito K; Arii S
    J Hepatol; 2010 Jan; 52(1):63-71. PubMed ID: 19913935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dual Aurora kinase inhibitor ZM447439 prevents anaplastic thyroid cancer cell growth and tumorigenicity.
    Baldini E; Tuccilli C; Prinzi N; Sorrenti S; Antonelli A; Gnessi L; Catania A; Moretti C; Mocini R; Carbotta G; Morrone S; Persechino S; Redler A; De Antoni E; D' Armiento M; Ulisse S
    J Biol Regul Homeost Agents; 2013; 27(3):705-15. PubMed ID: 24152827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitotic requirement for aurora A kinase is bypassed in the absence of aurora B kinase.
    Yang H; Burke T; Dempsey J; Diaz B; Collins E; Toth J; Beckmann R; Ye X
    FEBS Lett; 2005 Jun; 579(16):3385-91. PubMed ID: 15922328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts.
    Walsby E; Walsh V; Pepper C; Burnett A; Mills K
    Haematologica; 2008 May; 93(5):662-9. PubMed ID: 18367484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of cell cycle progression in human mesothelioma cells treated with gamma interferon.
    Vivo C; Lévy F; Pilatte Y; Fleury-Feith J; Chrétien P; Monnet I; Kheuang L; Jaurand MC
    Oncogene; 2001 Mar; 20(9):1085-93. PubMed ID: 11314045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZM 447439 inhibition of aurora kinase induces Hep2 cancer cell apoptosis in three-dimensional culture.
    Long ZJ; Xu J; Yan M; Zhang JG; Guan Z; Xu DZ; Wang XR; Yao J; Zheng FM; Chu GL; Cao JX; Zeng YX; Liu Q
    Cell Cycle; 2008 May; 7(10):1473-9. PubMed ID: 18418083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting aurora kinases with danusertib (PHA-739358) inhibits growth of liver metastases from gastroenteropancreatic neuroendocrine tumors in an orthotopic xenograft model.
    Fraedrich K; Schrader J; Ittrich H; Keller G; Gontarewicz A; Matzat V; Kromminga A; Pace A; Moll J; Bläker M; Lohse AW; Hörsch D; Brümmendorf TH; Benten D
    Clin Cancer Res; 2012 Sep; 18(17):4621-32. PubMed ID: 22753592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of AZD1152, a selective Aurora B kinase inhibitor, on Burkitt's and Hodgkin's lymphomas.
    Mori N; Ishikawa C; Senba M; Kimura M; Okano Y
    Biochem Pharmacol; 2011 May; 81(9):1106-15. PubMed ID: 21371446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Aurora B kinase sensitizes a subset of human glioma cells to TRAIL concomitant with induction of TRAIL-R2.
    Li J; Anderson MG; Tucker LA; Shen Y; Glaser KB; Shah OJ
    Cell Death Differ; 2009 Mar; 16(3):498-511. PubMed ID: 19079141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZM447439, a novel promising aurora kinase inhibitor, provokes antiproliferative and proapoptotic effects alone and in combination with bio- and chemotherapeutic agents in gastroenteropancreatic neuroendocrine tumor cell lines.
    Georgieva I; Koychev D; Wang Y; Holstein J; Hopfenmüller W; Zeitz M; Grabowski P
    Neuroendocrinology; 2010; 91(2):121-30. PubMed ID: 19923785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
    Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
    Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dietary flavonoid luteolin inhibits Aurora B kinase activity and blocks proliferation of cancer cells.
    Xie F; Lang Q; Zhou M; Zhang H; Zhang Z; Zhang Y; Wan B; Huang Q; Yu L
    Eur J Pharm Sci; 2012 Aug; 46(5):388-96. PubMed ID: 22449725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.